Lung Ultrasound for Physiotherapy in Hospitalized Patients With Respiratory Complications

NCT ID: NCT06412081

Last Updated: 2024-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-10

Study Completion Date

2025-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the relevance of using point-of-care lung ultrasound (LUS) in modifying the physiotherapist's treatment plan for patients hospitalized in a general ward.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hospitalized patients often confront respiratory issues stemming from diverse causes, such as pneumonia. Physiotherapists rely on a range of clinical and imaging data to inform their treatment decisions. Yet, they face challenges due to the absence of readily accessible, sensitive, specific, and reliable measurements to tailor the most effective physical therapeutic interventions based on individual clinical scenarios. Point-of-care Lung Ultrasound (LUS) holds promise in addressing these existing gaps.

This study aims to evaluate the impact of integrating LUS into clinical practice by comparing physiotherapists' initial clinical assessments and treatment plans with those made after incorporating LUS findings in patients admitted to a general ward.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hospitalization in a general ward
* Acute respiratory symptoms (\< 48h)
* Chest X-ray available within 24h before or after the use of LUS

Exclusion Criteria

* Any conditions precluding the use of LUS (thoracic skin lesions, thoracic bandage, subcutaneous emphysema)
* Inability to understand instructions due to cognitive impairment or due to language barrier
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

William Poncin, PT, PhD

PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cliniques universitaires Saint-Luc

Brussels, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

William Poncin

Role: CONTACT

Phone: +3227642316

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

William Poncin, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LUS-physio

Identifier Type: -

Identifier Source: org_study_id